Clinical evaluation of hydration index using a corneometer in metastatic melanoma patients treated with BRAF/MEK inhibitors: a prospective study

被引：0
|
作者：
Amabile, Simone [1 ]
Tonella, Luca [1 ]
Rubatto, Marco [1 ]
Argenziano, Giuseppe [2 ]
Babino, Graziella [2 ]
Frascione, Pasquale [3 ]
Dika, Emi [4 ,5 ]
Giacomelli, Luca [6 ]
Parodi, Aurora [7 ]
Quaglino, Pietro [1 ]
机构：
[1] Univ Turin, Dermatol Clin, Sch Med, Turin, Italy
[2] Univ Campania, Dermatol Unit, Naples, Italy
[3] Dermatol Hosp San Gallicano, Oncol Dermatol & Skin Tumor Prevent Unit, Rome, Italy
[4] IRCCS Azienda Osped Univ Bologna, Dermatol, Bologna, Italy
[5] Univ Bologna, Dermatol, Dept Expt Diagnost & Specialty Med DIMES, Bologna, Italy
[6] Polistudium SRL, Milan, Italy
[7] Univ Genoa, Dermatol Clin, Genoa, Italy
来源：
EUROPEAN JOURNAL OF DERMATOLOGY | 2022年 / 32卷 / 01期
关键词：
D O I：
10.1684/ejd.2022.4198
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：126 / 127
页数：2
相关论文
共 50 条
  • [1] Clinical evaluation of hydration index using a corneometer in metastatic melanoma patients treated with BRAF/MEK inhibitors: a prospective study
    Simone Amabile
    Luca Tonella
    Marco Rubatto
    Giuseppe Argenziano
    Graziella Babino
    Pasquale Frascione
    Emi Dika
    Luca Giacomelli
    Aurora Parodi
    Pietro Quaglino
    European Journal of Dermatology, 2022, 32 : 126 - 127
  • [2] Patterns of progression in metastatic melanoma patients treated with Braf and Mek inhibitors: an Italian Melanoma Intergroup (IMI) study
    Marconcini, R.
    Marra, E.
    De Rosa, F.
    Stucci, L. S.
    Orgiano, L.
    Ribero, S.
    Bloise, F.
    Antonuzzo, A.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [3] Metastatic melanoma patients treated with Braf and Mek inhibitors: Patterns of progression. An Italian Melanoma Intergroup study
    Marconcini, R.
    Marra, E.
    De Rosa, F.
    Stucci, S. L.
    Orgiano, L.
    Ribero, S.
    Bloise, F.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2017, 28 : 63 - 64
  • [4] Circulating Tumor DNA Correlates with Outcome in Metastatic Melanoma Treated by BRAF and MEK Inhibitors - Results of a Prospective Biomarker Study
    Forschner, Andrea
    Weissgraeber, Stephanie
    Hadaschik, Dirk
    Schulze, Martin
    Kopp, Maria
    Kelkenberg, Sabine
    Sinnberg, Tobias
    Garbe, Claus
    Biskup, Saskia
    Battke, Florian
    ONCOTARGETS AND THERAPY, 2020, 13 : 5017 - 5032
  • [5] Severe colitis in patients with melanoma treated with BRAF/MEK inhibitors
    Carbonnel, Franck
    Routier, Emilie
    Lazure, Thierry
    Mussini, Charlotte
    Bellanger, Christophe
    Merklen, Carine
    Bejou, Bakhtiar
    Buisson, Anthony
    Amiot, Aurelien
    Meyer, Antoine
    Dong, Catherine
    Robert, Caroline
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (07) : 792 - 799
  • [6] Cardiotoxicity in metastatic melanoma patients treated with BRAF and MEK inhibitors in a real-world setting
    Pedersen, Sidsel
    Larsen, Kirstine Ostenfeld
    Christensen, Alex Horby
    Svane, Inge Marie
    Zerahn, Bo
    Ellebaek, Eva
    ACTA ONCOLOGICA, 2022, 61 (01) : 45 - 51
  • [7] Unusual association of BRAF and MEK inhibitors: Clinical response of metastatic melanoma treated with dabrafenib- cobimetinib
    Leenhardt, Fanny
    Mbatchi, Litaty
    Evrard, Alexandre
    Cupissol, Didier
    Lesage, Candice
    BULLETIN DU CANCER, 2023, 110 (7-8) : 865 - 868
  • [8] BRAF and MEK inhibitors rechallenge as effective treatment for patients with metastatic melanoma
    Cybulska-Stopa, Bozena
    Rogala, Pawel
    Czarnecka, Anna M.
    Galus, Lukasz
    Dziura, Robert
    Rajczykowski, Marcin
    Kubiatowski, Tomasz
    Wisniewska, Magdalena
    Gega-Czarnota, Adrianna
    Teterycz, Pawel
    Ziobro, Marek
    Suwinski, Rafal
    Mackiewicz, Jacek
    Rutkowski, Piotr
    MELANOMA RESEARCH, 2020, 30 (05) : 465 - 471
  • [9] Efficacy and Adverse Events in Metastatic Melanoma Patients Treated with Combination BRAF Plus MEK Inhibitors Versus BRAF Inhibitors: A Systematic Review
    Greco, Austin
    Safi, Danish
    Swami, Umang
    Ginader, Tim
    Milhem, Mohammed
    Zakharia, Yousef
    CANCERS, 2019, 11 (12)
  • [10] Prognostic Role of Clinicopathological Characteristics and Serum Markers in Metastatic Melanoma Patients Treated with BRAF and MEK Inhibitors
    Janka, Eszter Anna
    Szabo, Imre Lorinc
    Kollar, Sandor
    Toka-Farkas, Tunde
    Vanyai, Beatrix
    Varvolgyi, Tunde
    Kapitany, Aniko
    Shabu, Hibah
    Szegedi, Andrea
    Emri, Gabriella
    CANCERS, 2024, 16 (17)
12345